| Wirth LJ, Allen AM, Posner MR, et al.
Phase I dose-finding study of paclitaxel with panitumumab, carboplatin and intensity-modulated radiotherapy in patients with locally advanced squamous cell cancer of the head and neck. [JOURNAL ARTICLE]
Ann Oncol 2009 Nov 5.
Abstract | Full Citation | Find Related Articles | | du Bois A, Huober J, Stopfer P, et al.
A phase I open-label dose-escalation study of oral BIBF 1120 combined with standard paclitaxel and carboplatin in patients with advanced gynecological malignancies. [JOURNAL ARTICLE]
Ann Oncol 2009 Nov 4.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Reynolds C, Barrera D, Jotte R, et al.
Phase II Trial of Nanoparticle Albumin-Bound Paclitaxel, Carboplatin, and Bevacizumab in First-line Patients with Advanced Nonsquamous Non-small Cell Lung Cancer. [JOURNAL ARTICLE]
J Thorac Oncol 2009 Oct 31.
Abstract | Full Citation | | Hirai H, Iwasawa Y, Okada M, et al.
Small-molecule inhibition of Wee1 kinase by MK-1775 selectively sensitizes p53-deficient tumor cells to DNA-damaging agents. [JOURNAL ARTICLE]
Mol Cancer Ther 2009 Nov 3.
Abstract | Full Citation | | Ha SW, Kim YJ, Kim W, et al.
Antitumor Effects of Camptothecin Combined with Conventional Anticancer Drugs on the Cervical and Uterine Squamous Cell Carcinoma Cell Line SiHa. [JOURNAL ARTICLE]
Korean J Physiol Pharmacol 2009 Apr; 13(2):115-121.
Abstract | Full Citation | | Hardy D, Cormier JN, Xing Y, et al.
Chemotherapy-Associated Toxicity in a Large Cohort of Elderly Patients with Non-small Cell Lung Cancer. [JOURNAL ARTICLE]
J Thorac Oncol 2009 Oct 30.
Abstract | Full Citation | | Reynolds C, Obasaju C, Schell MJ, et al.
Randomized Phase III Trial of Gemcitabine-Based Chemotherapy With In Situ RRM1 and ERCC1 Protein Levels for Response Prediction in Non-Small-Cell Lung Cancer. [JOURNAL ARTICLE]
J Clin Oncol 2009 Nov 2.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Ceresoli GL, Zucali PA, Gianoncelli L, et al.
Second-line treatment for malignant pleural mesothelioma. [JOURNAL ARTICLE]
Cancer Treat Rev 2009 Oct 28.
Abstract | Full Citation | | Girard N, Mornex F, Douillard JY, et al.
Is neoadjuvant chemoradiotherapy a feasible strategy for stage IIIA-N2 non-small cell lung cancer? Mature results of the randomized IFCT-0101 phase II trial. [JOURNAL ARTICLE]
Lung Cancer 2009 Oct 28.
Abstract | Full Citation | Find Related Articles | | Spigel DR, Greco FA, Zubkus JD, et al.
Phase II Trial of Irinotecan, Carboplatin, and Bevacizumab in the Treatment of Patients with Extensive-Stage Small-Cell Lung Cancer. [JOURNAL ARTICLE]
J Thorac Oncol 2009 Oct 28.
Abstract | Full Citation |   |
|
| |
Advertise on this site.
|
